PCR Biosystems increases operations for COVID-19 testing
PCR Biosystems have continued to scale up their operations to ensure the ongoing availability of COVID-19 test reagents
PCR Biosystems have continued to scale up their operations to ensure the ongoing availability of COVID-19 test reagents
The partnership aims to launch a ready-to-go processing solution that streamlines viral DNA/RNA extraction
Oxford Cannabinoid Technologies has announced the pre-clinical development of a new cannabinoid compound ‘OCT461201’ to treat IBS
The test results are designed to enable differential diagnosis in under 2.5 hours
Recent funding from the BARDA award helped the company accelerate development and validation
Collect our three guides for robust and reliable technologies to enable scientists in forensic and clinical laboratories
As a provider of advanced cell and particle instrumentation for the life science market, the funding aims to accelerate its research
The SAMBA II machines provide a simple and accurate system for the diagnosis of COVID-19 infection
In the wake of the pandemic, the strategic partnership aims to increase antigen production for diagnostic kits and vaccine development
Horizon Discovery and Pharmahungary have reported a micro-RNA compound suitable for further development
Initial shipments of FLIR A400/A700 thermal sensor solution will be prioritized for those responding to the COVID-19 virus
Join this free upcoming webinar for expert guidance on developing robust methods that improve the control of impurities
Join this new webinar to learn how Big Tuna, a fully automated buffer exchange platform, can simplify and accelerate your research
New IgM and IgG antibody assays will help indicate whether a person has developed immunity against COVID-19
The scientific community is working at full speed to fight the severe acute respiratory syndrome
A next-generation benchtop Energy Dispersive X-Ray Fluorescence (EDXRF) spectrometer for elemental analysis
The research-grade PepTivator Peptide Pools are designed to stimulate SARS-CoV-2 T-cells
The rapid delivery program is designed to provide critical laboratory equipment in this time of need
Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines
The partnership with Primer Design aims to distribute the Genesig CE-IVD & FDA-EUA COVID-19 qPCR kit to Europe and the U.S.
This collaboration hopes to deliver the unique ability to develop and deploy accredited physicochemical analysis techniques and methods
The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients
Discover how using Protein A and His1K biosensors can reduce the time of screening for bispecific antibodies